All Type of News
India patent case threatens cheap drug supply
Swiss-based Novartis attempts to weaken Indian Patent Law that threatens to restrict access to live-saving medicines for millions in the developing world, a civic group said Monday.
The warning came as the Supreme ...
Koh Kyung-suk named health & medical policy chief
The Ministry of Health and Welfare on Friday named Koh Kyung-suk, incumbent Social & Welfare Policy Chief, as the new Health & Medical Policy Chief in a partial shakeup.
The ministry also nominated Park Yong-hyun a...
Doctors demand state should be fully responsible for delivery accident
The Korean Medical Association (KMA) Friday protested against the government, demanding it provide full guarantees for any accidents arising from disputes in OB & GY department.
The KMA’s complaint comes after the ...
FTA to boost auto industry, but hurt drug makers
After four years of circular debate, political feuds and a last-minute tear gas attack, the free trade pact between Korea and the United States is finally set to take effect.
The ruling Grand National Party (GNP) e...
Korean Parliament ratifies FTA with US
The National Assembly on Tuesday passed the long-pending Korea-U.S. free trade agreement, with the ruling Grand National Party pressing ahead with the ratification process despite vehement objection from opposition pa...
Yuhan teams up with Boehringer Ingelheim
Yuhan Corp. said yesterday that it has established a marketing and distribution partnership with the Germany-based pharmaceutical company Boehringer Ingelheim.
Under the deal, Dong-A will be in charge of selling Bo...
Ilyang discontinues licensing-out negotiation over ilaprazole
Ilyang Pharmaceutical Co. said in a regulatory filing, Thursday, that it has suspended the negotiation of a licensing-out deal with one of multinational drug makers over ilaprazole, a new investigational proton pump i...
Lee likely to replace head of KFDA
President Lee Myung-bak is expected to name the next successor of the Korea Food and Drug Administration during early next year, according to multiple sources in the ruling bloc.
Kim Dae-kyung, professor of pharmac...
Local drug makers to take severe beating
The country’s pharmaceutical companies will face tough times ahead with the new Korea-U.S. Free Trade Agreement poised to strengthen patent rights for U.S. drug giants, heaping strain on the generic-focused Korean ind...
Government urged to shore up local pharmaceutical industry
The government needs to assess the damage that its free trade deal with the U.S. would cause in local pharmaceutical sector in the future and map out proper countermeasures, including state compenstation, the Korea Ph...
